Insmed Inc’s recently made public that its Officer Stacey Nicole Schaeffer Orlov acquired Company’s shares for reported $15.29 million on Jan 02 ’26. In the deal valued at $175.11 per share,87,290 shares were bought.
Then, Lewis William sold 10,699 shares, generating $1,786,457 in total proceeds. Upon selling the shares at $166.97, the Chair and CEO now owns 303,911 shares.
Before that, William Lewis bought 10,699 shares. Insmed Inc shares valued at $1,786,437 were divested by the Officer at a price of $166.97 per share.
A number of analysts have revised their coverage, including Rothschild & Co Redburn’s analysts, who began to cover the stock in early December with a ‘”a Buy”‘ rating. Wells Fargo started covering the stock on October 20, 2025. It rated INSM as “an Overweight”.
Price Performance Review of INSM
On Friday, Insmed Inc [NASDAQ:INSM] saw its stock jump 1.77% to $177.12. Over the last five days, the stock has lost -0.17%. Insmed Inc shares have risen nearly 157.18% since the year began. Nevertheless, the stocks have risen 1.77% over the past one year. While a 52-week high of $212.75 was reached on 01/02/26, a 52-week low of $60.40 was recorded on 01/02/26.
Levels Of Support And Resistance For INSM Stock
The 24-hour chart illustrates a support level at 174.48, which if violated will result in even more drops to 171.84. On the upside, there is a resistance level at 178.83. A further resistance level may holdings at 180.54.
How much short interest is there in Insmed Inc?
A steep rise in short interest was recorded in Insmed Inc stocks on 2025-12-15, growing by 56.0 shares to a total of 8.93 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 8.93 million shares.
The most recent change occurred on August 20, 2025 when William Blair began covering the stock and recommended ‘”an Outperform”‘ rating.
